Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice

作者: Jacinthe Aubert , Karima Begriche , Matthieu Delannoy , Isabelle Morel , Julie Pajaud

DOI: 10.1124/JPET.112.193813

关键词:

摘要: Clinical investigations suggest that hepatotoxicity after acetaminophen (APAP) overdose could be more severe in the context of obesity and nonalcoholic fatty liver disease. The pre-existence fat accumulation CYP2E1 induction major mechanisms accounting for such hepatic susceptibility. To explore this issue, experiments were performed obese diabetic ob/ob db/db mice. Preliminary male female wild-type, ob/ob, mice showed a selective increase activity However, triglycerides these animals significantly lower compared with Next, APAP (500 mg/kg) was administered mice, carried out 0.5, 2, 4, 8 h intoxication. Liver injury intoxication higher as assessed by plasma transaminases, histology, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. In however, extent glutathione depletion, levels APAP-protein adducts, c-Jun N-terminal kinase activation, changes gene expression, mitochondrial DNA not greater other genotypes. Furthermore, genotype lactate β-hydroxybutyrate specifically altered, whereas APAP-glucuronide intermediary between wild-type Thus, early APAP-induced than despite less similar basal transaminases. Hepatic have an important pathogenic role when occurs related metabolic disorders.

参考文章(61)
Anna Mae Diehl, Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 282, ,(2002) , 10.1152/AJPGI.00384.2001
Jacquelyn J Maher, Alcoholic steatosis and steatohepatitis. Seminars in gastrointestinal disease. ,vol. 13, pp. 31- 39 ,(2002)
Derick Han, Mie Shinohara, Maria D. Ybanez, Behnam Saberi, Neil Kaplowitz, Signal Transduction Pathways Involved in Drug-Induced Liver Injury Handbook of Experimental Pharmacology. ,vol. 196, pp. 267- 310 ,(2010) , 10.1007/978-3-642-00663-0_10
Jack A. Hinson, Dean W. Roberts, Laura P. James, Mechanisms of Acetaminophen-Induced Liver Necrosis Handbook of Experimental Pharmacology. ,vol. 196, pp. 369- 405 ,(2010) , 10.1007/978-3-642-00663-0_12
Viviane Trak-Smayra, Valérie Paradis, Julie Massart, Selim Nasser, Victor Jebara, Bernard Fromenty, Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet International Journal of Experimental Pathology. ,vol. 92, pp. 413- 421 ,(2011) , 10.1111/J.1365-2613.2011.00793.X
J Massart, MA Robin, F Noury, A Fautrel, P Lettéron, A Bado, PA Eliat, B Fromenty, Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. British Journal of Pharmacology. ,vol. 165, pp. 1361- 1374 ,(2012) , 10.1111/J.1476-5381.2011.01580.X
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Zaiqi Wang, Stephen D. Hall, Juan F. Maya, Lang Li, Ali Asghar, J. C. Gorski, Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. British Journal of Clinical Pharmacology. ,vol. 55, pp. 77- 85 ,(2003) , 10.1046/J.1365-2125.2003.01731.X
Otto Kučera, Tomáš Roušar, Pavla Staňková, Lenka Haňáčková, Halka Lotková, Miroslav Podhola, Zuzana Červinková, Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen. Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 323- 330 ,(2012) , 10.1111/J.1440-1746.2011.06807.X